ANAL CANCER
Clinical trials for ANAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ANAL CANCER trials appear
Sign up with your email to follow new studies for ANAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted early – what we know
Disease control TerminatedThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer and other solid tumors that had stopped responding to standard treatments. The goal was to see if the drug could shrink tumors or delay cancer growth. The trial was ter…
Matched conditions: ANAL CANCER
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug combo tested for tough cancers
Disease control TerminatedThis early-stage study tested a new drug called SO-C101, either alone or with another drug (pembrolizumab), in 115 people with advanced solid tumors like lung, kidney, or skin cancer. The main goal was to check safety and find the right dose. The study was stopped early, so resul…
Matched conditions: ANAL CANCER
Phase: PHASE1 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Battle of the scalpels: which early rectal cancer surgery wins?
Knowledge-focused TerminatedThis study compared two procedures for removing early-stage rectal cancer and precancerous growths: endoscopic submucosal dissection (ESD) and transanal endoscopic microsurgery (TEM). Researchers wanted to see which method more completely removes the tumor. The study planned to i…
Matched conditions: ANAL CANCER
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated May 05, 2026 11:56 UTC